What`s hiding behind IgA nephropathy?
... in Fabry´s disease and kidney tissue injury is still unclear • In females, there are highly variable levels of enzyme activity and broader range of clinical symptoms • Most females are affected; in various studies, 12% of Fabry´s patients on dialysis are women ...
... in Fabry´s disease and kidney tissue injury is still unclear • In females, there are highly variable levels of enzyme activity and broader range of clinical symptoms • Most females are affected; in various studies, 12% of Fabry´s patients on dialysis are women ...
Proclamation for Multiple System Atrophy (MSA) Awareness Month
... WHEREAS, symptoms include problems with balance, coordination, gait, bladder and bowel functions, speech, swallowing, and breathing ; and WHEREAS, there are some medications that treat the symptoms and some clinical trials for the development of improved treatment, much more research is needed for b ...
... WHEREAS, symptoms include problems with balance, coordination, gait, bladder and bowel functions, speech, swallowing, and breathing ; and WHEREAS, there are some medications that treat the symptoms and some clinical trials for the development of improved treatment, much more research is needed for b ...
Patient History - "Gigi" Doan, MD
... Last menstrual period __________ Are your periods regular? ________ How long do they last? ______________ Problems with periods? __________________________________________________Age first period began: ___________ Current birth control method_________________________________________________________ ...
... Last menstrual period __________ Are your periods regular? ________ How long do they last? ______________ Problems with periods? __________________________________________________Age first period began: ___________ Current birth control method_________________________________________________________ ...
Current Biomarker Knowledge and Clinical Practice
... • Prioritize CF Disease Aspects in Need of Biomarkers • Generate List of Patient Tissue/Fluid Sample Types and Relationship to Disease Aspects ...
... • Prioritize CF Disease Aspects in Need of Biomarkers • Generate List of Patient Tissue/Fluid Sample Types and Relationship to Disease Aspects ...
Opexa Therapeutics, Inc. NASDAQ: OPXA Precision Immunotherapy October 2014
... and adversely from those anticipated or implied in such statements. Our forward-looking statements are based upon our current expectations and involve assumptions that may never materialize or may prove to be incorrect. Actual results and the timing of events could differ materially from those antic ...
... and adversely from those anticipated or implied in such statements. Our forward-looking statements are based upon our current expectations and involve assumptions that may never materialize or may prove to be incorrect. Actual results and the timing of events could differ materially from those antic ...
demielinisation diseases of the nervous system actuality
... provide evidence of chronic inflammation of the central nervous system. The CSF is tested for ...
... provide evidence of chronic inflammation of the central nervous system. The CSF is tested for ...
We Are …your neighbors advancing medicine and healthcare.
... We are researching the therapeutic effects of sound and music in ...
... We are researching the therapeutic effects of sound and music in ...
Clinical factors influencing hospitalization in IBD patients Authors
... Over the course of the year, our patients have accumulated a total of 1354 days (3.7 years) of hospitalization. Regarding the demographic features of our case population, 84 (61%) were male, 92 (67%) were from urban regions, 85 (62%) were of 40 years or older. UC had on average longer hospitalizatio ...
... Over the course of the year, our patients have accumulated a total of 1354 days (3.7 years) of hospitalization. Regarding the demographic features of our case population, 84 (61%) were male, 92 (67%) were from urban regions, 85 (62%) were of 40 years or older. UC had on average longer hospitalizatio ...
Clinical Infectious Diseases
... recovered from a dog bite. Before 1885, when Louis Pasteur’s preventive vaccine brought greater security to the public from the presence of street dogs, folkloric treatments of infection from rabies may have “worked” because few supposedly rabid dogs actually had the disease. Otherwise, dog bite inf ...
... recovered from a dog bite. Before 1885, when Louis Pasteur’s preventive vaccine brought greater security to the public from the presence of street dogs, folkloric treatments of infection from rabies may have “worked” because few supposedly rabid dogs actually had the disease. Otherwise, dog bite inf ...
What is a drug?
... approved for therapeutic use (1985) • Incorrectly activates T cells, preventing them from responding to graft ...
... approved for therapeutic use (1985) • Incorrectly activates T cells, preventing them from responding to graft ...
Neurological Disorders Grades 9-12
... unknown). Inflammation breaks down myelin that forms a protective coat around the brain and spinal cord nerve fibers. Lost myelin is replaced by scars of hardened “sclerotic” tissue. Some nerve fibers are lost and this occurs in multiple places in the CNS. o Treatment: Research is still looking for ...
... unknown). Inflammation breaks down myelin that forms a protective coat around the brain and spinal cord nerve fibers. Lost myelin is replaced by scars of hardened “sclerotic” tissue. Some nerve fibers are lost and this occurs in multiple places in the CNS. o Treatment: Research is still looking for ...
In pathologic specimens, the demyelinating lesions of MS
... and which, unlike multiple sclerosis (MS), commonly spares the brain in the early stages. • NMO used to be considered as a special form of MS. During the past 10 years, however, the two diseases have been shown to be clearly different. • NMO is a B-cell-mediated disease associated with antiaquaporin ...
... and which, unlike multiple sclerosis (MS), commonly spares the brain in the early stages. • NMO used to be considered as a special form of MS. During the past 10 years, however, the two diseases have been shown to be clearly different. • NMO is a B-cell-mediated disease associated with antiaquaporin ...
Evaluation and Treatment of Chronic Pain: Emphasis on
... Phenotyping via QST /sensory exam, including provocative tests, depend on patient response ...
... Phenotyping via QST /sensory exam, including provocative tests, depend on patient response ...
New Treatments
... Center of Molecular Immunology 1st lung cancer vaccine Cimavax Not a cure: survival of patient - helps immune system - therapeutic vaccine ...
... Center of Molecular Immunology 1st lung cancer vaccine Cimavax Not a cure: survival of patient - helps immune system - therapeutic vaccine ...
Toward an Ontology for General Medical Science
... clinically abnormal and (ii) maximal, in the sense that it is not part of some larger combination. • Disease: A disposition (i) to undergo pathological processes that (ii) exists in an organism because of one or more disorders in that organism. ...
... clinically abnormal and (ii) maximal, in the sense that it is not part of some larger combination. • Disease: A disposition (i) to undergo pathological processes that (ii) exists in an organism because of one or more disorders in that organism. ...
Opexa Therapeutics, Inc.
... and adversely from those anticipated or implied in such statements. Our forward-looking statements are based upon our current expectations and involve assumptions that may never materialize or may prove to be incorrect. Actual results and the timing of events could differ materially from those antic ...
... and adversely from those anticipated or implied in such statements. Our forward-looking statements are based upon our current expectations and involve assumptions that may never materialize or may prove to be incorrect. Actual results and the timing of events could differ materially from those antic ...
... The design of vaccines Vaccination, the first great empirical success of immuno logy, has, by comparison with the major chemothera peutic drugs, the properties of a magic bullet. It is a remarkable fact, therefore, that despite an increasingly detailed appreciation of the workings of the immune sy ...
GUILDELINES FOR LABORATORY INVESTIGATIONS
... scheduled to be admitted to Concord Hospital on _______/______/________ for surgery under Dr ___________________________. We require all our patients to present at our Pre-Admission Clinic 7-10 days prior to their admission date, which not only assesses the patient medically, but provides the opport ...
... scheduled to be admitted to Concord Hospital on _______/______/________ for surgery under Dr ___________________________. We require all our patients to present at our Pre-Admission Clinic 7-10 days prior to their admission date, which not only assesses the patient medically, but provides the opport ...
Research Matters` Newsletter
... I hope to influence and develop Research ideas that have patient input and are driven by patients. We currently have some really exciting studies running, including the cytosponge study in the assessment of Barrett’s Oesophagus. We hope to launch a number of new home-grown, interventional studies in ...
... I hope to influence and develop Research ideas that have patient input and are driven by patients. We currently have some really exciting studies running, including the cytosponge study in the assessment of Barrett’s Oesophagus. We hope to launch a number of new home-grown, interventional studies in ...
Sandy Yuan - Crohn's Disease
... anHgens in environment (some unknown risk factors?) • SuscepHbility locus mapped to Chromosome 16 – CD19, involved in B‐lymphocyte funcHon – Sialophorin, involved in leukocyte adhesion – CD11 integrin cluster, involved in microbacterial cell adhesion – Interleukin‐4 receptor ...
... anHgens in environment (some unknown risk factors?) • SuscepHbility locus mapped to Chromosome 16 – CD19, involved in B‐lymphocyte funcHon – Sialophorin, involved in leukocyte adhesion – CD11 integrin cluster, involved in microbacterial cell adhesion – Interleukin‐4 receptor ...
Pharmacists - National Multiple Sclerosis Society
... What else can people do to feel their best? • Reach out to their support system; no one needs to be alone in coping with MS. ...
... What else can people do to feel their best? • Reach out to their support system; no one needs to be alone in coping with MS. ...
